|
US20070014787A1
(en)
*
|
1998-07-15 |
2007-01-18 |
Human Genome Sciences, Inc. |
71 human secreted proteins
|
|
US7479555B2
(en)
|
1999-07-21 |
2009-01-20 |
Ceres, Inc. |
Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US7534429B2
(en)
|
2000-11-29 |
2009-05-19 |
Hoffmann-La Roche Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
US7442777B2
(en)
|
2000-11-29 |
2008-10-28 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
US7431923B2
(en)
|
2005-01-03 |
2008-10-07 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
WO2003023007A2
(en)
|
2001-09-07 |
2003-03-20 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39
|
|
WO2004013311A2
(en)
*
|
2002-08-06 |
2004-02-12 |
Diadexus, Inc. |
Compositions and methods relating to ovarian specific genes and proteins
|
|
US20050037946A1
(en)
*
|
2003-01-13 |
2005-02-17 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419
|
|
EP1603585A2
(en)
|
2003-03-14 |
2005-12-14 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
|
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
|
WO2005019258A2
(en)
*
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
WO2005121778A2
(en)
*
|
2004-06-14 |
2005-12-22 |
Galapagos N.V. |
Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
|
|
EP1759205A4
(en)
*
|
2004-06-21 |
2008-02-27 |
Exelixis Inc |
PGDS AS PTEN WAY MODIFICATORS AND USE METHOD
|
|
WO2006006477A1
(ja)
*
|
2004-07-09 |
2006-01-19 |
Shionogi & Co., Ltd. |
骨疾患又は関節疾患に関与するポリペプチド及びそのｄｎａ
|
|
US20110009326A1
(en)
*
|
2004-07-16 |
2011-01-13 |
Yves Raymond |
Methods or use of lamin b1 nuclear antigen, fragments and compositions thereof, for inhibiting or reducing a thrombotic event
|
|
US8691772B2
(en)
*
|
2005-01-04 |
2014-04-08 |
Yeda Research And Development Co. Ltd. |
HSP60, HSP60 peptides and T cell vaccines for immunomodulation
|
|
CA2598436A1
(en)
|
2005-02-22 |
2006-08-31 |
Ceres, Inc. |
Modulating plant alkaloids
|
|
WO2006090389A2
(en)
|
2005-02-24 |
2006-08-31 |
Compugen Ltd. |
Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
|
|
GB0510627D0
(en)
|
2005-05-25 |
2005-06-29 |
Avidex Ltd |
Polypeptides
|
|
US8124839B2
(en)
|
2005-06-08 |
2012-02-28 |
Ceres, Inc. |
Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations
|
|
CN101443357A
(zh)
*
|
2005-08-12 |
2009-05-27 |
先灵公司 |
Mcp1融合物
|
|
GB0519376D0
(en)
*
|
2005-09-23 |
2005-11-02 |
Astrazeneca Ab |
Diagnostic method
|
|
US8110184B2
(en)
*
|
2005-09-30 |
2012-02-07 |
University Of Kentucky Research Foundation |
Ex vivo and in vivo methods and related compositions for generating hematopoietic stem cell populations
|
|
WO2007053648A2
(en)
|
2005-10-31 |
2007-05-10 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20070192885A1
(en)
*
|
2006-01-26 |
2007-08-16 |
Daniel Chelsky |
TAT-039 and methods of assessing and treating cancer
|
|
CA2647769C
(en)
|
2006-03-20 |
2015-05-26 |
Japan Science And Technology Agency |
Control of intracellular target molecule by ip3 receptor-binding protein
|
|
JP5146944B2
(ja)
*
|
2006-03-20 |
2013-02-20 |
独立行政法人理化学研究所 |
Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御
|
|
US8048421B2
(en)
|
2006-03-23 |
2011-11-01 |
Kyowa Hakko Kirin Co., Ltd. |
Agonist antibody to human thrombopoietin receptor
|
|
US20070237713A1
(en)
|
2006-04-04 |
2007-10-11 |
Fan Rong A |
PCan065 Antibody Compositions and Methods of Use
|
|
PL2032166T3
(pl)
|
2006-06-13 |
2013-09-30 |
Oncomed Pharm Inc |
Kompozycje i sposoby diagnozowania i leczenia nowotworów
|
|
JP4997547B2
(ja)
*
|
2006-06-15 |
2012-08-08 |
独立行政法人理化学研究所 |
炎症性疾患の判定方法
|
|
FR2908654B1
(fr)
|
2006-11-20 |
2014-04-04 |
Oreal |
Utilisation cosmetique de proteines de type chitinase
|
|
CA2670587A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Medical Research Council |
Assay
|
|
WO2008079406A2
(en)
*
|
2006-12-19 |
2008-07-03 |
Genentech, Inc. |
Gene expression markers for inflammatory bowel disease
|
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
CA2676008A1
(en)
|
2007-01-24 |
2008-07-31 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
WO2008092214A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Minomic International Limited |
Biomarkers for diabetes
|
|
WO2008100563A2
(en)
*
|
2007-02-14 |
2008-08-21 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
WO2008111634A1
(ja)
*
|
2007-03-15 |
2008-09-18 |
Reverse Proteomics Research Institute Co., Ltd. |
脳・神経に特異的あるいは神経分化に特異的なバイオマーカー
|
|
US8545888B2
(en)
*
|
2007-06-14 |
2013-10-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tendon stem cells
|
|
WO2009026622A1
(en)
*
|
2007-08-24 |
2009-03-05 |
Mylexa Pty Limited |
Modulators of hypersensitivity reactions
|
|
JP2009055838A
(ja)
*
|
2007-08-31 |
2009-03-19 |
Nipro Corp |
融合タンパク質、該融合タンパク質に関連する遺伝子、ベクター、形質転換体及び抗炎症性医薬組成物
|
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
|
US9132189B2
(en)
|
2008-07-08 |
2015-09-15 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
CN102316897B
(zh)
|
2008-07-08 |
2014-11-05 |
昂考梅德药品有限公司 |
Notch结合剂和拮抗剂及其应用方法
|
|
EA201990619A1
(ru)
|
2008-10-10 |
2019-07-31 |
Амген Инк. |
Fgf21 мутанты и их применение
|
|
AU2009308707A1
(en)
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
LIGHT targeting molecules and uses thereof
|
|
US8652785B2
(en)
*
|
2008-12-04 |
2014-02-18 |
Sanofi |
Method of screening a modulator of endothelial NO synthase comprising the use of heme binding protein 1
|
|
EP2373690B1
(en)
|
2008-12-08 |
2015-02-11 |
Compugen Ltd. |
Antibodies specific for tmem154
|
|
US20120052069A1
(en)
|
2009-05-05 |
2012-03-01 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
|
SG10201402038WA
(en)
|
2009-05-05 |
2014-07-30 |
Amgen Inc |
FGF21 Mutants And Uses Thereof
|
|
WO2010129890A2
(en)
*
|
2009-05-08 |
2010-11-11 |
Virginia Tech Intellectual Properties, Inc. |
Compounds and methods for inhibiting platelet aggregation
|
|
WO2010141999A1
(en)
*
|
2009-06-12 |
2010-12-16 |
The University Of Queensland |
Agents and methods for diagnosing and treating ankylosing spondylitis
|
|
AU2010262927A1
(en)
|
2009-06-17 |
2012-01-19 |
Amgen Inc. |
Chimeric FGF19 polypeptides and uses thereof
|
|
SG10201912571XA
(en)
|
2009-11-02 |
2020-02-27 |
Univ Washington |
Therapeutic nuclease compositions and methods
|
|
JP2013512672A
(ja)
*
|
2009-12-02 |
2013-04-18 |
アムジエン・インコーポレーテツド |
ヒトＦＧＦＲ１ｃ、ヒトβ−クロト−、ならびにヒトＦＧＦＲ１ｃおよびヒトβ−クロト−の両方に結合する結合タンパク質
|
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
|
AU2011205316B2
(en)
|
2010-01-13 |
2015-05-28 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
WO2011093176A2
(en)
|
2010-01-28 |
2011-08-04 |
Canon Kabushiki Kaisha |
Scintillator crystal body, method for manufacturing the same, and radiation detector
|
|
CA2695337A1
(en)
*
|
2010-03-04 |
2011-09-04 |
Ian De Belle |
Compositions and methods for inhibition of hiv
|
|
US8524217B2
(en)
|
2010-05-11 |
2013-09-03 |
Merck Sharp & Dohme Corp. |
MCP1-Ig fusion variants
|
|
US8775146B2
(en)
|
2010-07-22 |
2014-07-08 |
Shire Human Genetic Therapies, Inc. |
Crystal structure of human alpha-N-acetylglucosaminidase
|
|
WO2012062713A1
(en)
|
2010-11-08 |
2012-05-18 |
Novartis Ag |
Cxcr2 binding polypeptides
|
|
IT1406405B1
(it)
*
|
2010-12-27 |
2014-02-21 |
Univ Roma |
Molecole peptidiche per il trattamento di patologie mitocondriali
|
|
US20140056811A1
(en)
*
|
2010-12-27 |
2014-02-27 |
Compugen Ltd. |
New cell-penetrating peptides and uses thereof
|
|
KR20250037576A
(ko)
|
2011-04-29 |
2025-03-17 |
유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션 |
치료적 뉴클레아제 조성물 및 방법
|
|
CA2835477A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Method for the diagnosis of early rheumatoid arthritis
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
TWI589590B
(zh)
|
2012-11-07 |
2017-07-01 |
輝瑞股份有限公司 |
抗切口３（ａｎｔｉ-ｎｏｔｃｈ３）抗體及抗體-藥物共軛體
|
|
CN105073133B
(zh)
|
2012-12-21 |
2021-04-20 |
Aveo制药公司 |
抗gdf15抗体
|
|
EP2970468B1
(en)
|
2013-03-13 |
2021-07-07 |
Novartis AG |
Notch2 binding molecules for treating respiratory diseases
|
|
WO2015066550A1
(en)
|
2013-10-31 |
2015-05-07 |
Resolve Therapeutics, Llc |
Therapeutic nuclease-albumin fusions and methods
|
|
AU2014369861B2
(en)
*
|
2013-12-29 |
2018-09-13 |
Curelab Oncology, Inc. |
Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases
|
|
JP6721571B2
(ja)
*
|
2014-04-18 |
2020-07-15 |
▲煙▼台聚▲傑▼生物工程有限公司 |
１５種類の男性生殖関連タンパク質またはその組み合わせの使用
|
|
US20170240631A1
(en)
|
2014-08-08 |
2017-08-24 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
GB201508025D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Fabry disease gene therapy
|
|
PT3445397T
(pt)
|
2016-04-22 |
2023-01-13 |
Vaccinex Inc |
Exibição de proteína integral de membrana sobre viriões envelopados extracelulares de poxvírus
|
|
US20190241878A1
(en)
|
2016-07-01 |
2019-08-08 |
Resolve Therapeutics, Llc |
Optimized binuclease fusions and methods
|
|
KR102033215B1
(ko)
*
|
2016-07-05 |
2019-10-16 |
성균관대학교산학협력단 |
건선 유발 동물 모델 및 이의 용도
|
|
GB201700567D0
(en)
*
|
2017-01-12 |
2017-03-01 |
Genagon Therapeutics Ab |
Therapeutic agents
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
EP4295904A3
(en)
|
2017-05-24 |
2024-02-28 |
Thoeris GmbH |
Use of glutamine synthetase for treating hyperammonemia
|
|
DK3601358T5
(da)
|
2017-08-03 |
2024-09-02 |
Alector Llc |
Anti-trem2-antistoffer og fremgangsmåder til anvendelse deraf
|
|
CA3073537A1
(en)
|
2017-08-22 |
2019-02-28 |
Sanabio, Llc |
Soluble interferon receptors and uses thereof
|
|
AU2019347666B2
(en)
|
2018-09-28 |
2025-10-02 |
President And Fellows Of Harvard College |
Cellular reprogramming to reverse aging and promote organ and tissue regeneration
|
|
US12274733B2
(en)
|
2018-09-28 |
2025-04-15 |
President And Fellows Of Harvard College |
Cellular reprogramming to reverse aging and promote organ and tissue regeneration
|
|
US20210388345A1
(en)
*
|
2018-10-22 |
2021-12-16 |
Roche Sequencing Solutions, Inc. |
Profiling of rheumatoid arthritis autoantibody repertoire and peptide classifiers therefor
|
|
EP3935158A1
(en)
*
|
2019-03-07 |
2022-01-12 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
New vaccinal strategy to prevent or treat rheumatoid arthritis
|
|
AU2021211874A1
(en)
*
|
2020-01-21 |
2022-08-25 |
Boehringer Ingelheim International Gmbh |
Myeloid-derived growth factor for use in treating or preventing fibrosis, hypertrophy or heart failure
|
|
US20250270278A1
(en)
*
|
2020-12-07 |
2025-08-28 |
The Research Foundation For The State University Of New York |
Methods of making water-soluble protein formed in a bacterial expression system, compositions, and methods of use thereof
|
|
US12252518B2
(en)
|
2023-01-06 |
2025-03-18 |
Life Biosciences, Inc. |
Methods of treating non-arteritic anterior ischemic optic neuropathy
|
|
WO2024231931A1
(en)
*
|
2023-05-08 |
2024-11-14 |
Canopy Immuno-Therapeutics Ltd. |
Ig-like fusion proteins for treating immune thrombocytopenia
|
|
US20250108088A1
(en)
*
|
2023-10-02 |
2025-04-03 |
Matice BioSciences, Inc. |
Regenerative peptides and methods for use thereof
|